214 related articles for article (PubMed ID: 26382729)
1. Cohort comparison study of cardiac disease and atherosclerotic burden in type 2 diabetic adults using whole body cardiovascular magnetic resonance imaging.
Duce SL; Weir-McCall JR; Gandy SJ; Matthew SZ; Cassidy DB; McCormick L; Rauchhaus P; Looker H; Colhoun HM; Houston JG
Cardiovasc Diabetol; 2015 Sep; 14():122. PubMed ID: 26382729
[TBL] [Abstract][Full Text] [Related]
2. Whole-body cardiovascular MRI for the comparison of atherosclerotic burden and cardiac remodelling in healthy South Asian and European adults.
Weir-McCall JR; Cassidy DB; Belch JJ; Gandy SJ; Houston JG; Lambert MA; Littleford RC; Rowland J; Struthers AD; Khan F
Br J Radiol; 2016 Sep; 89(1065):20160342. PubMed ID: 27351693
[TBL] [Abstract][Full Text] [Related]
3. Whole body cardiovascular magnetic resonance imaging to stratify symptomatic and asymptomatic atherosclerotic burden in patients with isolated cardiovascular disease.
Weir-McCall JR; Duce SL; Gandy SJ; Matthew SZ; Martin P; Cassidy DB; McCormick L; Belch JJF; Struthers AD; Colhoun HM; Houston JG
BMC Med Imaging; 2016 Feb; 16():18. PubMed ID: 26923316
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of atheroma burden with sequential whole body contrast enhanced MR angiography: a feasibility study.
Weir-McCall JR; White RD; Ramkumar PG; Gandy SJ; Khan F; Belch JJ; Struthers AD; Houston JG
Int J Cardiovasc Imaging; 2016 May; 32(5):825-32. PubMed ID: 26809611
[TBL] [Abstract][Full Text] [Related]
5. Systemic cardiovascular complications in patients with long-standing diabetes mellitus: comprehensive assessment with whole-body magnetic resonance imaging/magnetic resonance angiography.
Weckbach S; Findeisen HM; Schoenberg SO; Kramer H; Stark R; Clevert DA; Reiser MF; Parhofer KG
Invest Radiol; 2009 Apr; 44(4):242-50. PubMed ID: 19212269
[TBL] [Abstract][Full Text] [Related]
6. Systemic arteriosclerosis is associated with left ventricular remodeling but not atherosclerosis: a TASCFORCE study.
Weir-McCall JR; Lambert M; Gandy SJ; Belch JJF; Cavin I; Henderson SA; Littleford R; Macfarlane JA; Matthew SZ; Stephen Nicholas R; Struthers AD; Sullivan F; White RD; Graeme Houston J
J Cardiovasc Magn Reson; 2018 Jan; 20(1):7. PubMed ID: 29382349
[TBL] [Abstract][Full Text] [Related]
7. Common carotid intima media thickness and ankle-brachial pressure index correlate with local but not global atheroma burden: a cross sectional study using whole body magnetic resonance angiography.
Weir-McCall JR; Khan F; Lambert MA; Adamson CL; Gardner M; Gandy SJ; Ramkumar PG; Belch JJ; Struthers AD; Rauchhaus P; Morris AD; Houston JG
PLoS One; 2014; 9(6):e99190. PubMed ID: 24933122
[TBL] [Abstract][Full Text] [Related]
8. Guideline treatment results in regression of atherosclerosis in type 2 diabetes mellitus.
Strang AC; van Wijk DF; Mutsaerts HJ; Stroes ES; Nederveen AJ; Rotmans JI; Rabelink TJ; Box FM
Diab Vasc Dis Res; 2015 Mar; 12(2):126-32. PubMed ID: 25589481
[TBL] [Abstract][Full Text] [Related]
9. Technical assessment of whole body angiography and cardiac function within a single MRI examination.
Gandy SJ; Lambert M; Belch JJ; Cavin ID; Crowe E; Littleford R; Macfarlane JA; Matthew SZ; Martin P; Nicholas RS; Struthers AD; Sullivan F; Waugh SA; White RD; Weir-McCall JR; Houston JG
Clin Radiol; 2015 Jun; 70(6):595-603. PubMed ID: 25791202
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of cardiovascular MR imaging biomarkers on outcome in peripheral arterial disease: a 6-year follow-up pilot study.
van den Bosch H; Westenberg J; Setz-Pels W; Kersten E; Tielbeek A; Duijm L; Post J; Teijink J; de Roos A
Int J Cardiovasc Imaging; 2016 Aug; 32(8):1281-8. PubMed ID: 27209283
[TBL] [Abstract][Full Text] [Related]
11. The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study.
Gorter PM; Visseren FL; Algra A; van der Graaf Y;
Diabet Med; 2007 Dec; 24(12):1352-60. PubMed ID: 18042079
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and Distribution of Atherosclerosis in a Low- to Intermediate-Risk Population: Assessment with Whole-Body MR Angiography.
Lambert MA; Weir-McCall JR; Salsano M; Gandy SJ; Levin D; Cavin I; Littleford R; MacFarlane JA; Matthew SZ; Nicholas RS; Struthers AD; Sullivan F; Henderson SA; White RD; Belch JJF; Houston JG
Radiology; 2018 Jun; 287(3):795-804. PubMed ID: 29714681
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes.
Segar MW; Patel KV; Vaduganathan M; Caughey MC; Jaeger BC; Basit M; Willett D; Butler J; Sengupta PP; Wang TJ; McGuire DK; Pandey A
Diabetologia; 2021 Jul; 64(7):1583-1594. PubMed ID: 33715025
[TBL] [Abstract][Full Text] [Related]
14. The additive effects of obesity on myocardial microcirculation in diabetic individuals: a cardiac magnetic resonance first-pass perfusion study.
Jiang L; Shi K; Guo YK; Ren Y; Li ZL; Xia CC; Li L; Liu X; Xie LJ; Gao Y; Shen MT; Deng MY; Yang ZG
Cardiovasc Diabetol; 2020 May; 19(1):52. PubMed ID: 32375795
[TBL] [Abstract][Full Text] [Related]
15. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus.
Rijzewijk LJ; van der Meer RW; Smit JW; Diamant M; Bax JJ; Hammer S; Romijn JA; de Roos A; Lamb HJ
J Am Coll Cardiol; 2008 Nov; 52(22):1793-9. PubMed ID: 19022158
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-Lymphocyte ratio is associated with arterial stiffness in diabetic retinopathy in type 2 diabetes.
Wang RT; Zhang JR; Li Y; Liu T; Yu KJ
J Diabetes Complications; 2015 Mar; 29(2):245-9. PubMed ID: 25483847
[TBL] [Abstract][Full Text] [Related]
17. Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitus.
El-Lebedy D; Rasheed E; Kafoury M; Abd-El Haleem D; Awadallah E; Ashmawy I
J Diabetes Complications; 2016; 30(4):580-5. PubMed ID: 26965796
[TBL] [Abstract][Full Text] [Related]
18. [Cardiovascular disease in patients with type 1 and type 2 diabetes in Spain].
Ortega E; Amor AJ; Rojo-Martínez G; Castell C; Giménez M; Conget I
Med Clin (Barc); 2015 Sep; 145(6):233-8. PubMed ID: 25561182
[TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus: long-term prognostic value of whole-body MR imaging for the occurrence of cardiac and cerebrovascular events.
Bamberg F; Parhofer KG; Lochner E; Marcus RP; Theisen D; Findeisen HM; Hoffmann U; Schönberg SO; Schlett CL; Reiser MF; Weckbach S
Radiology; 2013 Dec; 269(3):730-7. PubMed ID: 24023074
[TBL] [Abstract][Full Text] [Related]
20. Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophy.
Szwejkowski BR; Gandy SJ; Rekhraj S; Houston JG; Lang CC; Morris AD; George J; Struthers AD
J Am Coll Cardiol; 2013 Dec; 62(24):2284-93. PubMed ID: 23994420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
